Annovis Bio Inc. (ANVS) option IV into data

Annovis Bio Inc. (NYSE: ANVS) 30-day option implied volatility is at 333; compared to its 52-week range of 21 to 333 into topline efficacy data for phase II/III study of buntanetap in patients with mild to moderate Alzheimer's disease is expected in April.

You May Also Be Interested In

• Alphabet (GOOGL) call put ratio 1.6 calls to 1 put with a focus on June 22 weekly calls as share price down 6%
• Proshares Ultra SpaceX (SPCF) call put ratio 1.7 calls to 1 put with a focus on January 42 calls as share price down 21%
• Western Digital (WDC) call put ratio 1.2 calls to 1 put a focus on July 810 calls into Micron (MU) quarter results